Reckitt Benckiser files $1bn lawsuit against Indivior

The consumer goods group Reckitt Benckiser has filed a lawsuit against the pharmaceutical company, and former subsidiary, Indivior. In 2019, Reckitt Benckiser reached a $1.4bn settlement with the US Department of Justice relating to Indivior’s marketing of suboxone, an opioid addiction treatment. Reckitt Benckiser claims that the settlement caused its share value to fall by one fifth.